Semi-Annual Consolidated Statement Of Comprehensive Income

Kringle Pharma,Inc. - Filing #7338974

Concept 2023-10-01 to
2024-03-31
2022-10-01 to
2023-03-31
Semi-annual consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
-366,217,000 JPY
-315,557,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.